Cutaneous T-cell Lymphoma Stage I
2 clinical trials · Condition
◉ Watch Cutaneous T-cell Lymphoma Stage I
| Record | Firm | Date |
|---|---|---|
| Mechlorethamine Induced Contact Dermatitis Avoidance Study (NCT03380026) | Rochester Skin Lymphoma Medical Group, PLLC | 2017-12-13 |
| Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma (NCT00958074) | University of Washington | 2009-07-01 |
Track Cutaneous T-cell Lymphoma Stage I automatically
Every clearance here is in the API, with alerts when new ones post.